Teladoc Health Inc (TDOC)
12.84
+0.06
(+0.51%)
USD |
NYSE |
May 06, 14:10
Teladoc Health SG&A Expense (Quarterly): 349.39M for March 31, 2024
SG&A Expense (Quarterly) Chart
Historical SG&A Expense (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 349.39M |
December 31, 2023 | 309.56M |
September 30, 2023 | 354.18M |
June 30, 2023 | 358.13M |
March 31, 2023 | 345.42M |
December 31, 2022 | 322.56M |
September 30, 2022 | 345.64M |
June 30, 2022 | 335.50M |
March 31, 2022 | 296.85M |
December 31, 2021 | 290.92M |
September 30, 2021 | 276.70M |
June 30, 2021 | 278.29M |
March 31, 2021 | 259.40M |
December 31, 2020 | 531.68M |
September 30, 2020 | 135.53M |
June 30, 2020 | 122.88M |
March 31, 2020 | 96.80M |
December 31, 2019 | 88.11M |
September 30, 2019 | 87.76M |
June 30, 2019 | 83.02M |
March 31, 2019 | 80.18M |
Date | Value |
---|---|
December 31, 2018 | 76.02M |
September 30, 2018 | 69.09M |
June 30, 2018 | 60.90M |
March 31, 2018 | 58.59M |
December 31, 2017 | 61.35M |
September 30, 2017 | 47.76M |
June 30, 2017 | 35.75M |
March 31, 2017 | 35.44M |
December 31, 2016 | 31.39M |
September 30, 2016 | 30.04M |
June 30, 2016 | 26.14M |
March 31, 2016 | 26.08M |
December 31, 2015 | 24.12M |
September 30, 2015 | 21.89M |
June 30, 2015 | 24.88M |
March 31, 2015 | 19.99M |
December 31, 2014 | 11.72M |
September 30, 2014 | 10.00M |
June 30, 2014 | 8.502M |
March 31, 2014 | 8.007M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
83.02M
Minimum
Jun 2019
531.68M
Maximum
Dec 2020
263.42M
Average
293.89M
Median
SG&A Expense (Quarterly) Benchmarks
Omnicell Inc | 92.41M |
Phreesia Inc | 54.69M |
10x Genomics Inc | 85.77M |
Biote Corp | 26.19M |
American Shared Hospital Services | 1.76M |